Correlation Between Antibe Therapeutics and Cybin
Can any of the company-specific risk be diversified away by investing in both Antibe Therapeutics and Cybin at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Antibe Therapeutics and Cybin into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Antibe Therapeutics and Cybin Inc, you can compare the effects of market volatilities on Antibe Therapeutics and Cybin and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Antibe Therapeutics with a short position of Cybin. Check out your portfolio center. Please also check ongoing floating volatility patterns of Antibe Therapeutics and Cybin.
Diversification Opportunities for Antibe Therapeutics and Cybin
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Antibe and Cybin is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Antibe Therapeutics and Cybin Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cybin Inc and Antibe Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Antibe Therapeutics are associated (or correlated) with Cybin. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cybin Inc has no effect on the direction of Antibe Therapeutics i.e., Antibe Therapeutics and Cybin go up and down completely randomly.
Pair Corralation between Antibe Therapeutics and Cybin
If you would invest 1,003 in Cybin Inc on September 1, 2024 and sell it today you would earn a total of 22.00 from holding Cybin Inc or generate 2.19% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Antibe Therapeutics vs. Cybin Inc
Performance |
Timeline |
Antibe Therapeutics |
Cybin Inc |
Antibe Therapeutics and Cybin Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Antibe Therapeutics and Cybin
The main advantage of trading using opposite Antibe Therapeutics and Cybin positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Antibe Therapeutics position performs unexpectedly, Cybin can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cybin will offset losses from the drop in Cybin's long position.Antibe Therapeutics vs. Brainsway | Antibe Therapeutics vs. Venus Concept | Antibe Therapeutics vs. Tactile Systems Technology | Antibe Therapeutics vs. Icecure Medical |
Cybin vs. Mind Medicine | Cybin vs. Seelos Therapeutics | Cybin vs. GH Research PLC | Cybin vs. Awakn Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |